BlueWind Medical
Neuromodulation Therapy for Urge Urinary Incontinence
Startup B Health Tech & Life Sciences Est. 2010
Total Raised
$64M
B
Last Round
$64M
1 rounds
Investors
2
2 public
Team
2
51-200 employees
Confidence
99/100
News
17
articles
Patents
1
About
BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy for urge urinary incontinence (UUI). The company developed Revi. Its advanced implant design allows for the device to be miniature in size without the need for replacement surgeries for battery change, lead migration, or lead fracture. Its innovative external wearable technology powers the implant for a patient-centric approach to therapy allowing for increases in energy and stimulation sessions based on the patients’ needs, giving patients the flexibility to ensure the best possible outcome. BlueWind Medical has successfully completed several clinical studies with excellent results and is focused on bringing its implantable tibial neuromodulation system for the treatment of urge urinary incontinence to the market. BlueWind Medical was founded by the Rainbow Medical Group.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplantsSemiconductors & ElectronicsWearables
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatients
Business Model
B2B
Tags
neuro-stimulationneurologymedical-devicestherapeutic-devicesmobile-applicationstargeted-therapyminimally-invasivewearablewireless-controlurologytreatmentspersonalizationdigital-healthcare
Funding & Events
May 2022
B Round $64M
ConvaTec (Lead), Medtronic
News (17)
Dec 21, 2023 · www.prnewswire.com
growth-positive
BlueWind Medical Brings Revi Implantable Tibial Neuromodulation Device to Patients in Shreveport, Louisiana
CustomersExpand
Aug 16, 2023 · www.prnewswire.com
growth-positive
BlueWind Medical's Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence
CustomersPartners
May 1, 2023 · www.prnewswire.com
growth-positive
Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting
Customers
Apr 24, 2023 · www.prnewswire.com
growth-positive
BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting
Customers
Mar 8, 2023 · www.prnewswire.com
growth-positive
BlueWind Medical Announces Key Milestone as AMA Issues Unique Category III CPT Code for Subfascial Placement of Tibial Neurostimulators
Customers
Sep 27, 2022 · www.prnewswire.com
growth-positive
BlueWind Medical Appoints Dr. Liz Kwo to Board of Directors
Partners
May 9, 2022 · www.prnewswire.com
growth-positive
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
Investment
Jan 7, 2020 · www.massdevice.com
growth-positive
BlueWind Medical appoints new CEO
Management Changes
Nov 19, 2018 · www.newswire.ca
growth-positive
BlueWind Medical Appoints New Executive Chairman
Management Changes
Aug 30, 2018 · www.prnewswire.com
growth-positive
BlueWind Medical Announces Positive Long-Term Results of the BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator
Customers
Jul 30, 2018 · www.prnewswire.com
growth-positive
BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer
Management Changes
Jun 14, 2018 · www.prnewswire.com
growth-positive
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim™ Implantable Tibial Nerve Neuromodulator for Overactive Bladder
Customers
Jan 4, 2018 · www.prnewswire.com
growth-positive
BlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator
Customers
Sep 7, 2016 · www.medical-device.co.il
BlueWind Medical Announces CE-Mark for the BlueWind VIVENDI™ Miniature Implanted Wireless Stimulator to Treat Peripheral Pain
Sep 5, 2016 · www.israel21c.org
growth-positive
Now there's needle-free Botox for your bladder
Customers
Jun 15, 2016 · www.prnewswire.com
growth-positive
BlueWind Medical Announces CE-Mark for the First in the World Miniature Wireless Neurostimulator to Treat Overactive Bladder
Customers
Nov 12, 2015 · www.prnewswire.com
growth-positive
BlueWind Medical Announces Successful Completion of Patients' Follow-Up for its Peripheral Neuropathic Pain (PNP) Study Toward a CE Mark
Customers
Details
Product Stage
Clinical Trial
Employees
51-200
Exact Count
97
District
Center District
Founded
2010
Registrar
514504208
Crunchbase
bluewind-medical
Locations
Maskit Street 6, Herzliya, Israel
1389 Center Drive, Park City, UT 84098, USA
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Sep 28, 2024
Verified by
Sharon Shapira
Claimed
Yes
Missing
video or image, markets
Team (2)
Dan Lemaitre
Executive Chairman & CEO
Moshe Ben Chorin
VP R&D
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2014-07-10T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)